Tengion Inc - ESG Rating & Company Profile powered by AI
The Sustainability rating for Tengion Inc represents the company's reporting of the UN SDGs. This article includes a questions and answers section about Tengion Inc. This Disclosure score includes 17 UN Sustainable Development Goals including: 'No Poverty', 'Reduced Inequalities' and 'Life on Land'.
Tengion Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Tengion Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Tengion Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Tengion Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Tengion Inc report the average age of the workforce?
Sign up for free to unlockDoes Tengion Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Tengion Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Tengion Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Tengion Inc offer flexible work?
Sign up for free to unlockDoes Tengion Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Tengion Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Tengion Inc conduct supply chain audits?
Sign up for free to unlockDoes Tengion Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Tengion Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Tengion Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Tengion Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Tengion Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Tengion Inc disclose water use targets?
Sign up for free to unlockDoes Tengion Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Tengion Inc have a product recall in the last two years?
Sign up for free to unlockDoes Tengion Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Tengion Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Tengion Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Tengion Inc disclose parental leave metrics?
Sign up for free to unlockDoes Tengion Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Tengion Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Tengion Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Tengion Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Tengion Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Tengion Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Tengion Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Tengion Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Tengion Inc disclose its waste policy?
Sign up for free to unlockDoes Tengion Inc report according to TCFD requirements?
Sign up for free to unlockDoes Tengion Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Tengion Inc disclose energy use targets?
Sign up for free to unlockDoes Tengion Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Tengion Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Tengion Inc
These potential risks are based on the size, segment and geographies of the company.
Tengion, Inc. operates as a regenerative medicine company. The company focuses on discovering, developing, manufacturing, and commercializing a range of neo-organs or products composed of living cells with or without synthetic or natural materials that are implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product portfolio includes Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease; and Neo-Urinary Conduit, which is in Phase I clinical trial and used to replace the use of bowel tissue in bladder cancer patients requiring a non-continent urinary diversion after bladder removal surgery. The company has a license agreement with Children's Medical Center Corporation (CMCC) for the license of certain patent rights and intellectual property rights owned or controlled by CMCC related to tissue engineering technology. Tengion, Inc. was founded in 2003 and is headquartered in Winston-Salem, North Carolina. On December 29, 2014, Tengion, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.